Atrys Health 

€2.82
48
-€0.04-1.23% Today

Statistics

Day High
2.94
Day Low
2.82
52W High
3.51
52W Low
2.51
Volume
26,436
Avg. Volume
-
Mkt Cap
214.36M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5AugExpected
Q4 2022
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
-0.1
0.24
0.57
0.9
Expected EPS
N/A
Actual EPS
N/A

Financials

-14.94%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
425.49MRevenue
-63.55MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ATRY.MC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap11.66B
Guardant Health operates in precision oncology, offering liquid biopsies and cancer diagnostics, directly competing with Atrys Health's oncology diagnostics services.
Fulgent Genetics
FLGT
Mkt Cap470.46M
Fulgent Genetics offers comprehensive genetic testing, directly competing with Atrys Health's genetic diagnostics and personalized medicine services.
Bio-Rad Laboratories
BIO.B
Mkt Cap8.84B
Bio-Rad Laboratories provides clinical diagnostics and life science research products, competing with Atrys Health in the diagnostics and research services market.
Illumina
ILMN
Mkt Cap19.43B
Illumina provides sequencing and array-based solutions for genetic analysis, competing with Atrys Health in the genomics and personalized medicine sector.
Qiagen NV
QGEN
Mkt Cap7.92B
Qiagen offers sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the diagnostics and research market like Atrys Health.
Quest Diagnostics
DGX
Mkt Cap21.73B
Quest Diagnostics provides diagnostic testing, information, and services, competing with Atrys Health in the clinical diagnostics market.
Labcorp
LH
Mkt Cap21.74B
Laboratory Corporation of America offers clinical laboratory services and end-to-end drug development services, competing with Atrys Health in diagnostics and healthcare services.
Thermo Fisher Scientific
TMO
Mkt Cap174.55B
Thermo Fisher Scientific provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing with Atrys Health in offering comprehensive services for healthcare and research.

About

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic counselling; and diagnostic reports and genetic tests. It also provides telemedicine services, such as teleradiology, telecardiology, teleoncology, teledermatology, teleophthalmology, and teleconsultations; prevention plans for companies, which includes training plans on occupational risk prevention; Smart Data, a technological database for healthcare; and research and development services. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.
Show more...
CEO
Mr. Santiago De Torres Sanahuja
Employees
1985
Country
Spain
ISIN
ES0105148003

Listings

0 Comments

Share your thoughts

FAQ

What is Atrys Health stock price today?
The current price of ATRY.MC is €2.82 EUR — it has decreased by -1.23% in the past 24 hours. Watch Atrys Health stock price performance more closely on the chart.
What is Atrys Health stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Atrys Health stocks are traded under the ticker ATRY.MC.
Is Atrys Health stock price growing?
ATRY.MC stock has fallen by -2.76% compared to the previous week, the month change is a +2.92% rise, over the last year Atrys Health has showed a +0% increase.
What is Atrys Health market cap?
Today Atrys Health has the market capitalization of 214.36M
When is the next Atrys Health earnings date?
Atrys Health is going to release the next earnings report on August 05, 2026.
What is Atrys Health revenue for the last year?
Atrys Health revenue for the last year amounts to 425.49M EUR.
What is Atrys Health net income for the last year?
ATRY.MC net income for the last year is -63.55M EUR.
How many employees does Atrys Health have?
As of April 29, 2026, the company has 1,985 employees.
In which sector is Atrys Health located?
Atrys Health operates in the Health & Wellness sector.
When did Atrys Health complete a stock split?
Atrys Health has not had any recent stock splits.
Where is Atrys Health headquartered?
Atrys Health is headquartered in Madrid, Spain.